Erratum: Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease

Correction to: European Journal of Clinical Nutrition (2013) 67, 264–269; doi: 10.1038/ejcn.2012.217; published online 30 January 2013

Since the publication of this paper, the authors have noticed that it is incorrectly written in the methods, results, and a figure legend that human THP-1 monocytic cells were incubated with 4 μM of 1,25(OH)2D3. The concentration of 1,25(OH)2D3 should read 40 nM. This correction does not affect the conclusion that 1,25(OH)2D3 decreased MCP-1 release from THP-1 monocytes.

The authors apologize for any inconvenience caused.

Additional information

The online version of the original article can be found at 10.1038/ejcn.2012.217

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Alvarez, J., Zughaier, S., Law, J. et al. Erratum: Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease. Eur J Clin Nutr 67, 1228 (2013) doi:10.1038/ejcn.2013.190

Download citation